Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20386909 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)(TERMINATED)
Condition: Cancer
Intervention: Drug: VX-680 (an Aurora Kinase Inhibitor)

Indicates status has not been verified in more than two years